PAS
COLL icon

Point72 Asia (Singapore)’s Collegium Pharmaceutical COLL Stock Holding History

Point72 Asia (Singapore)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,867
Closed -$305K – 1114
2024
Q1 		$305K Buy
7,867
+6,646
+544% +$233K 0.08% 277
2023
Q4 		$37.6K Buy
+1,221
New +$30.6K 0.01% 356

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Point72 Asia (Singapore)'s COLL Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 7,867 shares — an estimated $305K sold.

Point72 Asia (Singapore) first reported a position in COLL in Q4 2023 and held it in 2 quarters. The position peaked at $305K in Q1 2024. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 7,867 Collegium Pharmaceutical shares in Q2 2024, an estimated $305K.
  • Point72 Asia (Singapore) first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Collegium Pharmaceutical position peaked at $305K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.